Crossmark

Topoisomerase inhibitors promote cancer cell motility via ROS-mediated activation of JAK2-STAT1-CXCL1 pathway

Published Online: 2019-08-22

Published Print: 2019-12

Authors

Liu, Jiafei http://orcid.org/0000-0001-9744-2232
Qu, Like

Meng, Lin

Shou, Chengchao
Funding

Funding for this research was provided by:

the Ministry of Science and Technology of China (2015CB553906)
License Information

Text and Data Mining valid from 2019-08-22

Version of Record valid from 2019-08-22
More Information

Article History

Received: 4 July 2019

Accepted: 1 August 2019

First Online: 22 August 2019

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: We declare that we have no financial and personal relationships with other people or organizations that can inappropriately influence our work.

Document is current